Merkel cell carcinoma (MCC) is a rare malignant neuroendocrine tumour of the skin (incidence: 0.2-0.45/10 5 ) that is more common in elderly, immunocompromised and HIV-infected individuals (1), with an overall 5-year survival rate: 30-60% (2). History of autoimmune conditions such as rheumatoid or psoriatic arthritis has been connected to a slightly increased MCC risk (3). A recent breakthrough was the identification of a novel polyomavirus (MCPyV) in association with MCC pathogenesis (4). Various combination schemes of conventional antineoplastic therapeutic modalities (surgery, radiotherapy and chemotherapy) are currently under evaluation for the treatment of metastatic MCC (2). Immunocryosurgery, i.e. liquid N 2 cryosurgery sessions during continuing daily topical imiquimod application, has been introduced in our hospital for the treatment of basal cell carcinoma (5), lentigo maligna (6) and Bowen's disease (7).Herein, we report on the successful treatment with immunocryosurgery of a patient with a loco-regional in transit MCC recurrence that was heralded by the development of a paraneoplastic polyarthritis syndrome.
CASE REPORTAn 84-year-old woman presented with a 2-week history of multiple (n = 11) cutaneous-subcutaneous nodules on her left tibia (Fig. 1a) and pain associated with local swelling of the right hip, right knee and both heels that precluded any movement (Karnofsky score: 30). The patient was treated during the preceding week with 16 mg methylprednisolone/day. Six months prior, a MCC, 2.5 cm in diameter, was removed from the left calf (T2cN0M0; Stage IIB) and 2 months prior she was hospitalised with a 3-day history of generalised symmetrical polyarthritis. No recurrence of MCC was evident at that time; the symptoms were attributed to the exacerbation of a known psoriatic arthritis. Τhe patient was treated with tapered 16 mg methylprednisolone/day with prompt improvement.During present hospitalisation laboratory evaluation was within normal limits except for increased erythrocyte sedimentation rate (94 mm/h), C-reactive protein (289 mg/l), a very low titre of rheumatoid factor (1/20, latex fixation test) and a low titre of antinuclear antibodies (1/160, indirect immunofluorescence); antibodies to extractable nuclear antigens and to double-stranded DNA, C3 and C4 complement levels and anti-cyclic citrullinated antibodies were within normal limits. Synovial fluid aspirate from the right knee supported the diagnosis inflammatory arthritis (30,000 leucocytes/mm 3 with 90% neutrophils; no malignant cells; no crystals; negative cultures).Biopsy of a nodule confirmed the recurrence of MCC. By immunohistochemistry (8) almost all tumour cells were positive for the large T-antigen of the MCPyV (antibody CM2B4, Santa Cruz Biotechnology Inc., sc-136172; Fig. S1e 1 ). Chest X-ray, abdomen ultrasound and CT scans of chest and abdomen did not show any lymph node or organ metastases. The constellation of physical, laboratory and radiologic findings set the diagnosis of in transit recurrence of MCC (T2N2M0; stage ...